Several studies indicated that BBB disruption is a modus operandi for metastasizing cells from triple-negative breast cancer (TNBC) and basal-type breast cancers but not those from HER2/neu-positive breast cancer [50, 51], but the reason for this difference is currently unknown. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.